Background. Middle-aged and older adults with diabetes are heterogeneous and may be characterized as belonging to one of three clinical groups: a relatively healthy group, a group having characteristics likely to make diabetes selfmanagement diffi cult, and a group with poor health status for whom current management targets have uncertain benefi t.
T HE aim of type 2 diabetes management is to prevent diabetes complications or the worsening of existing complications. To achieve this, patients must follow a multipronged self-management regimen, generally involving several (or many) medications and diffi cult behavioral changes. The effi cacy of these interventions depends on the ability of patients to self-manage their diabetes and on patients ' surviving long enough to experience treatment benefi t.
However, older type 2 diabetes patients are a heterogeneous group ( 1 , 2 ) . Most are relatively healthy and capable of selfmanagement; others have health-related or psychosocial challenges that can impair their ability to follow a complicated regimen, and some with poor health status may have decreased expected survival ( 3 ) . Older adults, particularly those over 75 years old and those with multiple comorbidities or functional disability, have been underrepresented in the studies that have provided the evidence for current diabetes management ( 4 ) . So, it is not clear to what extent current guidelines and targets are applicable to their disease circumstances.
Previously, using a combination of clinical and functional criteria, we characterized middle-aged and older adults with diabetes as belonging to one of three clinical groups: a relatively healthy group, a group having characteristics likely to poor health status for whom current diabetes management targets may not yield benefi t ( 5 ) . Using population-based survey data, we investigated the prevalence of these clinical groups by age, and we examined the sociodemographic and diabetes characteristics of the groups. We found that adults in the older age groups were more likely to have diffi culty in self-managing their diabetes and to have poor health status. Yet, we also found that middle-aged adults constituted the largest absolute number of diabetes patients likely to have diffi culty in self-management; this age group also contributed sizeable numbers to the poor health status-uncertain benefi t clinical group.
Complex and poor health status, with a burden of comorbidities, functional impairment, and often cognitive impairment, confuses notions of appropriate diabetes management ( 6 -10 ) . Indeed, what constitutes quality of care for diabetes patients with complex health status has yet to be determined. Such patients would be expected to have limited survival. Although researchers have investigated the mortality outcomes of older adults with diabetes, no large studies have focused on the mortality of diabetes patients in relation to multifaceted clinical complexity, including their existing diabetes complications, geriatric conditions, and functional impairment T HE aim of type 2 diabetes management is to prevent diabetes complications or the worsening of existing complications. To achieve this, patients must follow a multipronged self-management regimen, generally involving several (or many) medications and diffi cult behavioral changes. The effi cacy of these interventions depends on the ability of patients to self-manage their diabetes and on patients ' surviving long enough to experience treatment benefi t.
Complex and poor health status, with a burden of comorbidities, functional impairment, and often cognitive impairment, confuses notions of appropriate diabetes management ( 6 -10 ) . Indeed, what constitutes quality of care for diabetes patients with complex health status has yet to be determined. Such patients would be expected to have limited survival. Although researchers have investigated the mortality outcomes of older adults with diabetes, no large studies have focused on the mortality of diabetes patients in relation to multifaceted clinical complexity, including their existing diabetes complications, geriatric conditions, and functional impairment Previously, using a combination of clinical and functional criteria, we characterized middle-aged and older adults with diabetes as belonging to one of three clinical groups: a relatively healthy group, a group having characteristics likely to make diabetes self-management difficult, and a group with poor health status for whom current diabetes management targets may not yield benefit (5). Using population-based survey data, we investigated the prevalence of these clinical groups by age, and we examined the sociodemographic and diabetes characteristics of the groups. We found that adults in the older age groups were more likely to have difficulty in self-managing their diabetes and to have poor health status. Yet, we also found that middle-aged adults constituted the largest absolute number of diabetes patients likely to have difficulty in selfmanagement; this age group also contributed sizeable numbers to the poor health status-uncertain benefit clinical group.
Complex and poor health status, with a burden of comorbidities, functional impairment, and often cognitive impairment, confuses notions of appropriate diabetes
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The goal of this study was to investigate the mortality of the clinical groups that we had previously described and to examine age, other sociodemographic characteristics, and certain diabetes characteristics as predictors of mortality. We hypothesized that adults with diffi culty in self-management and adults with poor health status would have substantial all-cause mortality, beyond that associated with age.
M ethods

Study Design
We performed secondary analysis of population-based longitudinal health interview survey data.
Data
The data used in this study are from the 2004, 2006, and 2008 waves of the Health and Retirement Study (HRS) and from the supplemental HRS 2003 Diabetes Study ( 13 , 14 ) . The HRS is a nationally representative longitudinal health interview survey of a cohort of adults age 51 years and older in the United States. It is sponsored by the National Institute on Aging and performed by the Institute for Social Research at the University of Michigan. Its 2003 Diabetes Study surveyed respondents with diabetes about their diabetes treatment and self-management ; included was a self-administered fi nger-stick kit to collect blood spot samples to measure respondents ' hemoglobin A1c (HbA1c) levels ( 15 ) .
The HRS was approved by the Health Sciences Institutional Review Board at the University of Michigan. The data used for this analysis are publicly available and contain no unique identifi ers, thus assuring respondent anonymity.
Study Population
Of the 18,937 HRS respondents interviewed in 2004 whose age was 51 years and older, we identifi ed 3,507 respondents who reported being told by a doctor that they had diabetes or high blood sugar. These respondents, who included adults living in the community and those residing in long-stay nursing facilities, represent 13.6 million adults 51 years and older with diabetes in the United States in that year. When the respondent was unable to be interviewed (eg, due to medical and/or cognitive problems), a proxy respondent ( n = 371), most often the spouse ( n = 227), was enlisted to answer questions for that respondent according to study protocol.
Of the 3,507 respondents 51 years and older who reported having diabetes in 2004, 1,690 participated in the HRS 2003 Diabetes Study, and, of those, 1,136 had HbA1c values available from this study ( 15 
Description of Health Status in Diabetes
We previously defi ned three health status groups, drawing upon clinical insight and the medical literature ( 5 ) . These clinical groups are mutually exclusive and together include all respondents. 
Uncertain Benefi t Group (previously designated Limited
Benefi t Group). Characterized by: -Dementia, -Dependency in two or more ADLs, OR -Living in a long-stay nursing facility.
Variables and Their Measurement
Comorbid Chronic Diseases. -The HRS provides selfreport information on a number of chronic diseases (in addition to diabetes): hypertension, heart disease, chronic lung disease, cancer, musculoskeletal conditions, stroke, and psychiatric problems. Respondents reported whether or not a physician had diagnosed them with each disease. Questions about the diseases included those indicating disease activity or severity (eg, requiring medication). Because we also examined disability, we attempted to avoid activity/ severity indicators that were inherently functional in nature. In our analyses, we limited chronic diseases to their active/ severe forms ( 16 , 17 ) . We summed the seven diseases to derive a count of comorbid diseases.
Vision Impairment. -We defi ned vision impairment as blindness or poor eyesight despite use of corrective lenses.
Cognitive Impairment. -The HRS assesses for cognitive impairment in one of two ways ( 16 , 18 , 19 ) . For self-respondents, the presence of cognitive impairment is determined using a management (6) (7) (8) (9) (10) . Indeed, what constitutes quality of care for diabetes patients with complex health status has yet to be determined. Such patients would be expected to have limited survival. Although researchers have investigated the mortality outcomes of older adults with diabetes, no large studies have focused on the mortality of diabetes patients in relation to multifaceted clinical complexity, including their existing diabetes complications, geriatric conditions, and functional impairment (11, 12) .
The goal of this study was to investigate the mortality of the clinical groups that we had previously described and to examine age, other sociodemographic characteristics, and certain diabetes characteristics as predictors of mortality. We hypothesized that adults with difficulty in self-management and adults with poor health status would have substantial all-cause mortality, beyond that associated with age.
METHODS
Study Design
Data
The data used in this study are from the 2004, 2006, and 2008 waves of the Health and Retirement Study (HRS) and from the supplemental HRS 2003 Diabetes Study (13, 14) . The HRS is a nationally representative longitudinal health interview survey of a cohort of adults age 51 years and older in the United States. It is sponsored by the National Institute on Aging and performed by the Institute for Social Research at the University of Michigan. Its 2003 Diabetes Study surveyed respondents with diabetes about their diabetes treatment and self-management; included was a selfadministered finger-stick kit to collect blood spot samples to measure respondents' hemoglobin A1c (HbA1c) levels (15) .
The HRS was approved by the Health Sciences Institutional Review Board at the University of Michigan. The data used for this analysis are publicly available and contain no unique identifiers, thus assuring respondent anonymity.
Study Population
Of the 18,937 HRS respondents interviewed in 2004 whose age was 51 years and older, we identified 3,507 respondents who reported being told by a doctor that they had diabetes or high blood sugar. These respondents, who included adults living in the community and those residing in long-stay nursing facilities, represent 13.6 million adults 51 years and older with diabetes in the United States in that year. When the respondent was unable to be interviewed (eg, due to medical and/or cognitive problems), a proxy respondent (n = 371), most often the spouse (n = 227), was enlisted to answer questions for that respondent according to study protocol.
Of the 
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Cognitive Impairment. -The HRS assesses for cognitive impairment in one of two ways ( 16 , 18 , 19 ) . For self-respondents, the presence of cognitive impairment is determined using a performance-based measure, a modifi ed version of the Telephone Interview for Cognitive Status, a validated cognitive screening instrument patterned on the Mini-Mental State Examination and specifi cally designed for populationbased studies. We defi ned dementia as a score of 0 -6 on the 27-point cognitive scale; we defi ned mild cognitive impairment (cognitive impairment, no dementia) as a score of 7 -11.
For respondents unable to complete the interview, we made use of an 11-point scale comprised of the proxy ' s assessment of the respondent ' s memory (excellent -0, very good -1, good -2, fair -3, and poor -4); the proxy ' s assessment of the respondent ' s IADL diffi culties (ranging from 0 to 5); and the interviewer ' s assessment of the respondent ' s cognitive impairment (no impairment -0, may have impairment -1, and has impairment -2). The scale was divided into the three cognitive categories: normal, 0 -2; mild cognitive impairment, 3 -5; and dementia, 6 -11. (The respondent and proxy cognitive scales are modifi cations of the scales used in the analyses of our previously published study [ 20 ] ) .
Disability. -ADLs included bathing, dressing, eating, toileting, and transferring; IADLs included meal preparation, shopping, money management, telephone use, and taking medications. We determined the number of respondents reporting ADL and IADL dependencies in two steps: fi rst, those who reported having diffi culty with the task or inability to perform the task because of health or memory problems (diffi culty), and, second, those who reported both having diffi culty with and receiving assistance for the task (dependency).
Living Status. -We defi ned residence in a long-stay nursing facility as including only respondents living in nursing facilities long term for custodial care, not those residing short term in subacute, rehabilitation, or skilled nursing facilities.
Sociodemographic Characteristics. -Sociodemographic variables included age , gender , race (Caucasian, African American, and Hispanic) , living arrangement (married, unmarried living with other[s], and unmarried living alone) , educational attainment , and net worth ( 13 ) . We divided respondents into three age groups: 51 -64 years old (middleaged, currently included in denominators for clinical performance targets); 65 -75 years old (Medicare population, also currently included in denominators for these targets); and 76 years and older (Medicare population, not currently included in denominators for clinical performance targets). Mortality. -The HRS conducts exit interviews with designated proxy respondents for those HRS respondents who have died. These HRS mortality data are cross-referenced with the National Center for Health Statistics National Death Index.
Indicators for Diabetes
Statistical Analysis
The HRS employs a multistage probability sample of households that is nationally representative. To adjust for the complex sample design of the HRS and the differential probability of selection and for nonresponse, all analyses were weighted and adjusted using the statistical package STATA (Release 10. Here also the time of interest was from the month of each respondent ' s 2004 wave interview to December, 2008. Models were adjusted for clinical group, age, gender, race, living arrangement, education, and net worth. As a last step, we introduced age group-clinical group interaction terms into the hazard models, to enable examination of the relationship between age and health status in contributing to mortality. We used the combination of the age group 51 -64 years old and the Relatively Healthy clinical group as the reference; we then analyzed the hazard ratios for the eight interaction terms (eight combinations of the age groups and the clinical groups). Table 1 shows the respondents ' sociodemographic characteristics for the 2004 wave, fi rst, for the entire sample of respondents reporting diabetes (column 1) and, next, for each clinical group (columns 2 -4). These proportions are the presence of cognitive impairment is determined using a performance-based measure, a modified version of the Telephone Interview for Cognitive Status, a validated cognitive screening instrument patterned on the Mini-Mental State Examination and specifically designed for population based studies. We defined dementia as a score of 0-6 on the 27-point cognitive scale; we defined mild cognitive impairment (cognitive impairment, no dementia) as a score of 7-11.
R esults
For respondents unable to complete the interview, we made use of an 11-point scale comprised of the proxy's assessment of the respondent's memory (excellent -0, very good -1, good -2, fair -3, and poor -4); the proxy's assessment of the respondent's IADL difficulties (ranging from 0 to 5); and the interviewer's assessment of the respondent's cognitive impairment (no impairment -0, may have impairment -1, and has impairment -2). The scale was divided into the three cognitive categories: normal, 0-2; mild cognitive impairment, 3-5; and dementia, 6-11. (The respondent and proxy cognitive scales are modifications of the scales used in the analyses of our previously published study [20] ).
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performance-based measure, a modifi ed version of the Telephone Interview for Cognitive Status, a validated cognitive screening instrument patterned on the Mini-Mental State Examination and specifi cally designed for populationbased studies. We defi ned dementia as a score of 0 -6 on the 27-point cognitive scale; we defi ned mild cognitive impairment (cognitive impairment, no dementia) as a score of 7 -11. For respondents unable to complete the interview, we made use of an 11-point scale comprised of the proxy ' s assessment of the respondent ' s memory (excellent -0, very good -1, good -2, fair -3, and poor -4); the proxy ' s assessment of the respondent ' s IADL diffi culties (ranging from 0 to 5); and the interviewer ' s assessment of the respondent ' s cognitive impairment (no impairment -0, may have impairment -1, and has impairment -2). The scale was divided into the three cognitive categories: normal, 0 -2; mild cognitive impairment, 3 -5; and dementia, 6 -11. (The respondent and proxy cognitive scales are modifi cations of the scales used in the analyses of our previously published study [ 20 ] ) .
Statistical Analysis
The HRS employs a multistage probability sample of households that is nationally representative. To adjust for the complex sample design of the HRS and the differential probability of selection and for nonresponse, all analyses were weighted and adjusted using the statistical package STATA (Release 10. We used standard descriptive methods (frequencies, means, and standard deviations) to estimate the prevalence of respondents meeting criteria for the clinical groups and to make comparisons among groups (weighted Chi square test). We performed survival analysis (Kaplan Meier survival curves) based on the respondents ' health status at baseline. The time of interest extended from the month of the 2004 wave interview for each respondent (eg, February, 2004) to December, 2008, with a mean follow-up for the study sample of 49.0 months. To further investigate mortality, we performed step-wise Cox proportional hazard models for the full 2004 wave sample and for the 2003 subsample. In these models, we incorporated respondents ' updated health status (membership in one of the three clinical groups), using data from the 2006 and 2008 waves. Here also the time of interest was from the month of each respondent ' s 2004 wave interview to December, 2008. Models were adjusted for clinical group, age, gender, race, living arrangement, education, and net worth. As a last step, we introduced age group-clinical group interaction terms into the hazard models, to enable examination of the relationship between age and health status in contributing to mortality. We used the combination of the age group 51 -64 years old and the Relatively Healthy clinical group as the reference; we then analyzed the hazard ratios for the eight interaction terms (eight combinations of the age groups and the clinical groups). Table 1 shows the respondents ' sociodemographic characteristics for the 2004 wave, fi rst, for the entire sample of respondents reporting diabetes (column 1) and, next, for each clinical group (columns 2 -4). These proportions are weighted to be representative of adults aged 51 years and older with diabetes in the United States in 2004. (Differences in the estimates and prevalences in Table 1 from those in our previously published study are primarily due to our use of the revised cognitive scales.) Of the 13.6 million adults 51 years and older with diabetes, our analyses estimated that 7.7 million were relatively healthy, 4.3 million had clinical characteristics likely to make self-management diffi cult, and 1.6 million had characteristics consistent with uncertain benefi t from current management interventions. As noted in our previous study, although older adults were overrepresented in the Self-Management Diffi culty Group, middle-age adults contributed the largest numbers to this clinical group (approximately 1.7 million people nationally). Similarly, although adults 76 years and older contributed the largest number (700,000) and largest percentage (44.1%) to the Uncertain Benefi t Group, adults 51 -64 years old and adults 65 -75 years old combined to contribute 900,000 individuals to this group. In contrast, although adults 76 years and older were underrepresented in the Relatively Healthy Group, this clinical group included a sizeable percentage (13.6%) and number (1 million) of these older adults. Figure 1 illustrates the unadjusted survival curves for the three clinical groups. The survival probabilities for the groups at 5 years were: Relatively Healthy Group, 90.8%; Self-Management Diffi culty Group, 79.4%; and Uncertain Benefi t Group, 52.5%. Table 2 provides the distribution (bivariate) of respondents ' characteristics by their mortality status at 5 years. Adults 76 years and older had 35.0% mortality, compared with 11.7% for the 51 -to 64 -year old age group and 14.7% for the 65 -to 75 -year old age group. Respondents who were unmarried, those with less education, and those with lower net worth also had increased mortality. There were no associations of gender or race with mortality. For the subsample of respondents who participated in the 2003 Diabetes Note: Population estimates for the age groups are rounded to the nearest 100,000. The columns present the percentages of the total population (column 1) and the respective clinical groups (columns 2, 3, and 4) for each variable. Proportions are related to the columns and not the rows; the columns for each variable (not the rows) add to 100%. For example, of those respondents in the Relatively Healthy Group, 55.7% are 51 -64 years old, 30.7% are 65 -75 years old, and 13.6% are 76 years and older. p V alue from the χ 2 test for the association between the indicated variable and belonging to the Clinical Groups.
R esults
* Weighted percentages (and population estimates) were derived using Health and Retirement Study respondent population weights to adjust for differential probability of selection into the sample and differential nonresponse. nation of age group 76 years and older and the Uncertain Benefi t Group (hazard ratio 12.7). The interaction was driven by membership in the Uncertain Benefi t Group, such that both adults 65 -75 years old in the Uncertain Benefi t Group and adults 76 years and older in the Uncertain Benefi t Group had substantially increased likelihood of mortality, beyond the effect of age and the effect of being in the Uncertain Benefi t Group when considered individually. Figure 2 depicts mortality at 5 years for the respondents stratifi ed by both age and clinical groups. Adults 51 -64 years old and those 65 -75 years old had similar mortality when in the Relatively Healthy Group (approximately 8%) and in the Self-Management Diffi culty Group (approximately 16%). However, mortality for adults 65 -75 years old in the Uncertain Benefi t Group (41.8%) was twice that for adults 51 -64 years old in the same group (18.0%). In contrast to the two younger groups, mortality was substantially increased for adults 76 years and older for each of the clinical groups, reaching 68.1% for the Uncertain Benefi t Group.
We next examined the association between the clinical groups and mortality ( Table 3 ) . Using the Relatively Healthy Group as the reference, the unadjusted hazard ratio for mortality for the Self-Management Diffi culty Group was 2.4 (95% confi dence interval 1.9 -3.1) and for the Uncertain Benefi t Group was 7.1 (95% confi dence interval 5.6 -9.0). These hazard ratios remained statistically signifi cant in our model adjusting for sociodemographic characteristics (age, gender, race, living arrangement, education, and net worth): Model 1 ( c olumn 1): 2.0 for the Self-Management Diffi culty Group and 5.5 for the Uncertain Benefi t Group. We found similar hazard ratios for the clinical groups in the model examining the subsample of respondents who participated in the 2003 Diabetes Study (Model 3 [ c olumn 3] ). Here, use of insulin was also a predictor of mortality (hazard ratio 1.6).
As a fi nal step, we tested Model 1 for interactions and found a statistically signifi cant age group-clinical group interaction (Model 2 [ c olumn 2]). Two interaction terms proved to be signifi cant and substantial in the positive direction: the combination of age group 65 -75 years old and the Uncertain Benefi t Group (hazard ratio 7.0) and the combi- Weighted percentages were derived using Health and Retirement Study respondent population weights to adjust for differential probability of selection into the sample and differential non response. Note: Proportions are related to the rows and not the columns; the rows for each variable (not the columns) add to 100%. p Value from the χ 2 test for the association between the indicated variable and 5-y mortality.
* Weighted percentages were derived using Health and Retirement Study respondent population weights to adjust for differential probability of selection into the sample and differential nonresponse. † For comparison, the HbA1c (mean ± SE ) for 314 subsample respondents who died was 7.3 ± 0.1.
Diabetes patients in the Self-Management Diffi culty Group and the Uncertain Benefi t Group have not been well represented in the large clinical trials that have produced much of the evidence for current management interventions ( 4 ) . Rather, these trials have typically enrolled middle-aged adults who are relatively healthy. Yet, our study found that relatively healthy 65 -to 75 -year old adults had the same 5 -year survival as the younger cohort. It remains to be demonstrated that the outcomes found in younger healthier adults with diabetes can be reproduced in older age groups and in those with complex health status. Nonetheless, our fi ndings suggest that older, more clinically complex , adults may well survive long enough to experience treatment benefi t, for both primary and secondary prevention.
Our fi ndings add to the literature of quality assessment in diabetes care ( 6 -10 ) . The fi nding that medically complex patients survive to 5 years suggests that these patients may be appropriate to include in assessments of clinical quality (ie, to include in quality assessment denominators). Determinations of quality at the institution and system level may benefi t from additional measures of quality that take into account health status complexity and other issues relevant to older adults (eg, geriatric conditions such as falling).
A strength of this research is that it is based on a large, nationally representative longitudinal survey (HRS) that provides detailed data on chronic diseases, task-specifi c disabilities, and mortality and includes a performancebased determination of cognitive ability. Further, the HRS samples across the age range of older adults, including the oldest old, and it samples both community-dwelling and nursing facility respondents.
This study has several limitations. First, the HRS is based on self-report data. In particular, the diagnosis of diabetes is self-reported, with no distinction between type 1 and type 2 diabetes. HbA1c data were limited to respondents who participated in the 2003 Diabetes Study, which had only a 48% usable rate; it is possible that a larger sample size could have produced signifi cant fi ndings. Also, we were unable to examine the roles of diabetes duration and of age of diabetes onset. Last, our analyses examined survival and mortality and not life expectancy.
This study found substantial survival for middle-aged and older adults with diabetes, regardless of the complexity of their health status. Clinically, these fi ndings have implications for the management of older diabetes patients with comorbidity and disability burdens. At a policy level, these fi ndings have implications for how older complex diabetes patients can be supported in their self-management and in how the quality of their care is best assessed. At a research level, these fi ndings support the inclusion of older complex patients in clinical trials, to determine whether their outcomes replicate those of younger healthier diabetes patients. Such trials will also benefi t from examining the trajectories of diabetes patients with varying ages of onset and with varying disease durations to determine effi cacy of interventions. Figure 2 . Mortality at 5 y by a ge and c linical g roups. Weighted percentages were derived using Health and Retirement Study respondent population weights to adjust for differential probability of selection into the sample and differential non response.
D iscussion
This study examines the mortality of middle-aged and older adults with diabetes in relation to the complexity of their health status. It builds on our previous work that characterized adults with diabetes as relatively healthy, likely to have diffi culty in diabetes self-management, or having poor health status leading to uncertain benefi t from current management interventions ( 5 ) . Confi rming our hypothesis, we found that health status (Relatively Healthy, Self-Management Diffi culty, and Uncertain Benefi t groups) predicted future mortality. Yet, more signifi cantly, this study reveals the substantial survival of middle-aged and older adults with diabetes, regardless of health status. For all age groups and clinical groups, except adults 76 years and older in the Uncertain Benefi t Group, survival at 5 years exceeded 50%.
Clinically, these fi ndings contribute to the current discussion about the appropriate quality guidelines and targets in the care of older diabetes patients and about the means needed to achieve them ( 6 -10 ) . Large numbers of middle-aged and older adults with diabetes have characteristics likely to make self-management of their diabetes diffi cult ( 1 -3 ) . However, the substantial survival of the Self-Management Diffi culty Group, even among the oldest adults, indicates the potential benefi t for these patients of pursuing interventions that prevent or delay the onset or worsening of macrovascular and microvascular diabetes complications. For such interventions to be successful, these patients require additional support to perform self-management, whether provided by the health care system or by personal caregivers (formal or informal).
Adults 51 -75 years old with diabetes who had dementia, had ADL dependency, or resided in long-stay nursing facilities likewise had substantial 5 -year survival. Discussion with these patients and their families about the benefi ts and the risks and burdens of current diabetes management and about their personal goals of care is required. 
